Tag: plasma therapy manufacturing
Australia’s CSL outlines USD 1.5B plan to boost US plasma therapy manufacturing capacity
Australian biotech firm CSL has announced plans to invest approximately USD 1.5 billion in the United States over the next five years, with the company stating the move is aimed at strengthening domestic manufacturing capacity for plasma-derived therapies.
Featured Article
Xometry CEO Sanjeev Singh Sahni on how AI and digital networks are reshaping manufacturing supply chains
Australian manufacturers have long competed against distance. In an exclusive interview with Australian Manufacturing, Xometry CEO Sanjeev Singh Sahni discusses how AI can help manufacturers access more production capacity and simplify traditionally email-driven supply chains.
